BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24633222)

  • 1. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN).
    Damania P; Sen B; Dar SB; Kumar S; Kumari A; Gupta E; Sarin SK; Venugopal SK
    PLoS One; 2014; 9(3):e91745. PubMed ID: 24633222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
    Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
    Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
    PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes.
    Bandopadhyay M; Banerjee A; Sarkar N; Panigrahi R; Datta S; Pal A; Singh SP; Biswas A; Chakrabarti S; Chakravarty R
    BMC Cancer; 2014 Sep; 14():721. PubMed ID: 25260533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
    Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
    Front Immunol; 2021; 12():661204. PubMed ID: 33995383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN/Akt pathway.
    Ha HL; Yu DY
    World J Gastroenterol; 2010 Oct; 16(39):4932-7. PubMed ID: 20954279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
    Hou Z; Quan J
    Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
    Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
    Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS; Xia N; Sun H; Kong Y
    J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV‑related hepatocellular carcinoma by targeting estrogen receptor-α.
    Chen JJ; Tang YS; Huang SF; Ai JG; Wang HX; Zhang LP
    Oncol Rep; 2015 Feb; 33(2):792-8. PubMed ID: 25483016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
    Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
    PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro.
    Wu G; Yu F; Xiao Z; Xu K; Xu J; Tang W; Wang J; Song E
    Br J Cancer; 2011 Jun; 105(1):146-53. PubMed ID: 21629246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12.
    Yin D; Wang Y; Sai W; Zhang L; Miao Y; Cao L; Zhai X; Feng X; Yang L
    Oncol Rep; 2016 Oct; 36(4):2305-12. PubMed ID: 27571873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.